The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends. The fund targets companies that have raised payouts for at least five consecutive years, while excluding the highest-yielding names and firms with payout ratios above 75%, a methodology designed to emphasize dividend quality and sustainability rather than raw yield.
DGRO holds roughly 395 securities and is dominated by large-capitalization companies. Sector exposure is led by financials (about 19.5%), followed by information technology (roughly 18.3%), health care (about 17.3%), consumer staples (approximately 12.6%), and industrials (around 11.2%). Energy, utilities, and consumer discretionary round out the meaningful allocations. Top holdings include JPMorgan Chase (JPM), Microsoft (MSFT), Apple (AAPL), Exxon Mobil (XOM), Johnson & Johnson (JNJ), AbbVie (ABBV), and Broadcom (AVGO). I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The fund carries a 0.08% expense ratio and manages more than $40 billion in assets under management (AUM), making it one of the largest and most cost-efficient products in the dividend-growth category. Its beta, historically below that of the broader market, reflects the defensive character of its holdings.
Dividend-growth investing sits at the intersection of income and quality. In the current environment, investors have balanced demand for steady payout streams against sensitivity to interest rates, which influence the relative appeal of dividend-paying equities versus fixed income. Financials have benefited from a resilient credit backdrop, while large-cap technology names that also grow dividends provide a bridge between value and growth styles.
Healthcare and consumer staples contribute defensive ballast, though pharmaceutical pricing and litigation dynamics remain recurring considerations. Energy holdings add cyclical exposure tied to commodity prices, while industrials reflect capital-spending trends and broader economic activity. The gradual re-emergence of value-oriented leadership has supported diversified dividend strategies, even as growth-heavy segments of the market attract attention.
DGRO's recent price action reflects a recovery after a softer stretch. Over the trailing 30 days, the fund has advanced roughly 6%, while the prior three-month period showed a modest decline near 4%. This pattern suggests a stabilization and rebound from a mid-cycle pullback rather than a sharp, trend-driven move.
Much of the recent strength has come from the fund's heavyweight financial and technology names, which tend to carry outsized influence on returns given the portfolio's concentration near the top. Energy holdings have contributed periodic volatility tied to oil prices, while defensive staples and healthcare positions have helped temper drawdowns. The fund's relatively low beta has kept its movements more contained than the broader market during bouts of volatility.
Looking ahead, several structural factors are likely to shape DGRO's trajectory. Interest-rate policy remains central, as higher yields can pressure the relative appeal of dividend equities while easing tends to support them. Inflation trends will influence both corporate pricing power and payout growth, while the earnings cycle across the fund's largest financial, technology, and healthcare holdings will drive underlying dividend durability.
Sector rotation between growth and value styles, capital flows into and out of dividend strategies, and the competitive landscape among low-cost ETFs all merit attention. Regulatory developments affecting financials, healthcare, and energy could create selective headwinds or tailwinds. While no outcome is assured, the fund's diversified, quality-focused construction positions it to participate across a range of macroeconomic scenarios without making concentrated bets on any single theme.
In my own work, Tickeron’s AI Screener has become a useful complement when evaluating dividend strategies like DGRO. It lets me scan for related opportunities across technical signals, fundamentals, and performance filters, helping refine ideas without replacing core holdings. The platform surfaces patterns that align with specific risk and theme parameters I track regularly.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Moving Average Convergence Divergence (MACD) for DGRO turned positive on October 07, 2026. Looking at past instances where DGRO's MACD turned positive, the stock continued to rise in 46 of 54 cases over the following month. The odds of a continued upward trend are 85%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on DGRO as a result. In 71 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
DGRO moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for DGRO crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.
Following a +1.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where DGRO advanced for three days, in 292 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 307 of 394 cases where DGRO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DGRO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
DGRO broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue